Key facts
- It has raised $13.8M; the latest was Early Stage VC in Jan 2026.
- Notable investors include CAS Star, Beijing Jiuzhou Xinnuo Investment Fund Management, Kesheng Investment, Qiji Investment, Shenzhen Jiadaogu Investment Management — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Lead Healthcare (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Lead Healthcare (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lead Healthcare (Biotechnology)
Manufacturer of microfluidic systems designed for life science instruments and the biopharmaceutical industry. The company offers microfluidic-based systems, AI-driven analysis modules, integrated automation, supporting biochips, reagents, and consumables, configurable workflows, monitoring and control interfaces, validated protocols, and interoperability with laboratory platforms, enabling clients with advanced medical devices and biopharmaceutical equipment.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2023
- Website
- leadhealthcare.com.cn/
- Ownership
- Privately Held (backing)
Lead Healthcare (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lead Healthcare (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lead Healthcare (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.